Oragenics's total assets for Q4 2025 were $10.07B, an increase of 79139.14% from the previous quarter. OGEN total liabilities were $1.79B for the fiscal quarter, a 62053.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.